The following clinically significant adverse reactions associated with Eltrombopag are described in other sections.
Hepatic Decompensation in Patients with Chronic Hepatitis C
Hepatotoxicity
Increased Risk of Death and Progression of Myelodysplastic Syndromes to Acute Myeloid Leukemia
Thrombotic/Thromboembolic Complications
from FDA,2021.10
Eltrombopag is an important drug for the treatment of thrombocytopenia, and its application value and potential risks need to be fully understood.Does eltrombopag have side effects···【more】
Article source:Lucius LaosRelease date:2025-03-24Recommended:80
Understanding the potential side effects of medications can help you manage health risks more scientifically.What are the side effects of using eltrombopag?Some patients may experi···【more】
Article source:Lucius LaosRelease date:2025-03-21Recommended:51
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: